Results 11 to 20 of about 17,929 (144)

Characteristics of incident substance-induced psychosis compared to incident first-episode psychosis. A nationwide register-linkage study. [PDF]

European Psychiatry, 2023
Introduction To date, most of the substance-induced psychosis (SIP) risk factor research has focused on meth/amphetamine use with cross-sectional study designs.
J. Jeyaniroshan, P. Sassi
doaj   +2 more sources

Frequency and patterns of substance-induced psychosis in persons with concurrent mental health and substance use disorders during the COVID-19 pandemic: A Norwegian register-based cohort study [PDF]

European Psychiatry
Background Substance use may be associated with the onset of psychotic symptoms, necessitating treatment for individuals with comorbid mental health and substance use disorders (MHD/SUD). COVID-19 significantly impacted individuals with MHD/SUD, reducing
Marja Leonhardt, Jørgen G. Bramness, Eline Borger Rognli, Lars Lien   +3 more
doaj   +2 more sources

T83. SUBSTANCE-INDUCED PSYCHOSIS LINKED TO BOTH INFECTIONS AND SCHIZOPHRENIA [PDF]

Schizophrenia Bulletin, 2020
Abstract Background Substance-induced psychosis is an under-researched phenomenon, and little is known about its etiology (other than exposure to substances) and long-term prognosis. In this presentation, we aim to present results from two recent studies, one of which was recently published and the ...
Hjorthøj, Carsten, Starzer, Marie, Benros, Michael, Nordentoft, Merete   +3 more
openaire   +2 more sources

Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorders. A nationwide register-linkage study [PDF]

European Psychiatry
Introduction Far less is known about the preceding factors of antipsychotic use among persons with substance-induced psychosis (SIP) and first-episode psychosis (FEP).
J. Jeyapalan, S. Niemela, H. Taipale
doaj   +2 more sources

Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis [PDF]

BMC Psychiatry
Background Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications.
Mohammad Saad Javed, Rayane El-Khoury, Amr Ahmed Taha, Shuja Mohd Reagu   +3 more
doaj   +2 more sources

Clinical phenotypes of psychosis and reoffending risk among justice-involved adolescents: a population-based cohort study [PDF]

Frontiers in Psychiatry
BackgroundHigh reoffending rates among justice-involved adolescents necessitate identifying modifiable risk factors. Given the elevated prevalence of psychosis in this group compared to the general adolescent population, determining its contribution ...
Emaediong I. Akpanekpo, Tony Butler
doaj   +2 more sources

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis [PDF]

Journal of Addiction, 2015
Background. Substance-induced psychotic disorder (SIPD) is a diagnosis constructed to distinguish substance-induced psychotic states from primary psychotic disorders. A number of studies have compared SIPD persons with primary psychotic patients, but there is little data on what differentiates substance use disorder (SUD) individuals with and without ...
Zhornitsky, Simon, Tikàsz, Andràs, Rizkallah, Élie, Chiasson, Jean-Pierre, Potvin, Stéphane   +4 more
openaire   +4 more sources

Substance abuse in first-episode psychosis at Chris Hani Baragwanath Hospital [PDF]

South African Journal of Psychiatry
Background: In South Africa, the use of substances is associated with serious health challenges, exacerbated by limited health resources. Substance use is often associated with first-episode psychosis (FEP).
Precious N. Shandu, Yumna Minty
doaj   +2 more sources

Antipsychotic Potential of Opioids: Rethinking Substance-Induced Psychosis and Treatment Stratification [PDF]

Journal of Clinical Medicine
Substance-induced psychosis is a recognized clinical entity, commonly linked to cannabinoids, stimulants, hallucinogens, alcohol, and polysubstance use. These agents may provoke transient or persistent psychotic symptoms during intoxication or withdrawal.
Angelo G. I. Maremmani, Filippo Della Rocca, Silvia Bacciardi, Manuel Glauco Carbone, Icro Maremmani   +4 more
openaire   +2 more sources

Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World Study [PDF]

Pharmaceuticals
Background: Dual disorders (DDs) describe the coexistence of substance use disorder (SUD) and another mental health condition, commonly within psychotic and affective categories.
Alessio Mosca, Clara Cavallotto, Stefania Chiappini, Giacomo d’Andrea, Francesco Di Carlo, Carlotta Marrangone, Rita Allegretti, Nicola Ciraselli, Maria Pepe, Luigi Dattoli, Beatrice Petrosino, Andrea Di Cesare, Valerio Ricci, Marco Di Nicola, Mauro Pettorruso, Giovanni Martinotti   +15 more
doaj   +2 more sources